// App-Quantinova.ai

2837 : The CDK4/6 inhibitor has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma

Researchers

Presenter

  • Bo Mi Ku

Principal Investigators

  • Jiae Koh

  • Yeon-Hee Bae

  • Jong-Mu Sun

  • Se-hoon Lee

  • Jin Seok Ahn

  • Keunchil Park

  • Myung-Ju Ahn

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma of the head and neck

  • Retinoblastoma

  • Solid malignancies

Biomarkers

  • Cyclin D1

  • Cyclin Dependent Kinase Inhibitor 2A

  • Cyclin-dependent kinase 4

  • Extracellular signal-regulated kinase

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • Abemaciclib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved